Another $1bn+ investment boost, this time at sites in Denmark and Texas, will push Fujifilm Diosynth Biotechnologies into the top tier of CDMOs based on cell culture capacity. The $1.6 billion will be used to expand cell culture manufacturing capabilities at contract development and manufacturing organization (CDMO) Fujifilm’s Hillerød facility in Denmark and across the Atlantic at its single-use campus in College Station, Texas. “Currently, the market for antibody drugs is expected to grow at an annual rate of over…